| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-200b | Erlotinib | epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) | Sensitive | High | 22045191 | |
| miR-200c | Erlotinib | epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) | Sensitive | High | 22045191 | |
| miR-200a | Erlotinib | pancreatic adenocarcinoma | Sensitive | High | 23918833 | |
| miR-200b | Erlotinib | pancreatic adenocarcinoma | Sensitive | High | 23918833 | |
| miR-200c | Erlotinib | pancreatic adenocarcinoma | Sensitive | High | 23918833 | |
| miR-200c | Erlotinib | non-small cell lung cancer | Resistant | Low | 23963283 | |
| miR-200b | Erlotinib | non-small cell lung cancer | Sensitive | Low | 24199791 | |
| miR-200 | Erlotinib | cancer | Sensitive | Low | 24830724 |